Literature DB >> 33459811

[Contrast-enhanced mammography].

Eva M Fallenberg1.   

Abstract

Early detection is of great importance for the successful treatment of breast cancer and for a good prognosis. Contrast-enhanced mammography and especially contrast-enhanced spectral mammography (CESM) show promising initial results and are a valuable addition to currently available methods. The advantage of these methods is that imaging of both breasts can be performed in a single examination with a single contrast agent application. The accuracy of CESM is similar to that of magnetic resonance imaging (MRI), easily available at low costs, which is why this procedure is increasingly used in the diagnostic work up of breast cancer. CESM is also a good alternative to MRI if this cannot be performed due to contraindications.

Entities:  

Keywords:  Breast cancer; Contrast-enhanced spectral mammography; Early diagnosis; Magnetic resonance imaging; Quality control

Mesh:

Substances:

Year:  2021        PMID: 33459811     DOI: 10.1007/s00117-021-00805-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  3 in total

Review 1.  Prognostic factors in breast cancer: a brief review.

Authors:  M Fernö
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

2.  Human breast uptake of radioactive iodine.

Authors:  B A Eskin; J A Parker; J G Bassett; D L George
Journal:  Obstet Gynecol       Date:  1974-09       Impact factor: 7.661

3.  Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.

Authors:  Marc B I Lobbes; Ulrich Lalji; Janneke Houwers; Estelle C Nijssen; Patty J Nelemans; Lori van Roozendaal; Marjolein L Smidt; Esther Heuts; Joachim E Wildberger
Journal:  Eur Radiol       Date:  2014-04-03       Impact factor: 5.315

  3 in total
  1 in total

1.  A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography.

Authors:  Luca Nicosia; Anna Carla Bozzini; Simone Palma; Marta Montesano; Filippo Pesapane; Federica Ferrari; Valeria Dominelli; Anna Rotili; Lorenza Meneghetti; Samuele Frassoni; Vincenzo Bagnardi; Claudia Sangalli; Enrico Cassano
Journal:  Cancers (Basel)       Date:  2022-09-05       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.